Your Article Summary
Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
The American Journal of Gastroenterology, 01/22/08
Gisbert JP et al. - Quadruple therapy is generally recommended as second-line therapy after Helicobacter pylori (H. pylori) eradication failure...Ten-day levofloxacin-based rescue therapy constitutes an encouraging second-line strategy, representing an alternative to quadruple therapy in patients with previous proton pump inhibitor-clarithromycin-amoxicillin failure, being simple and safe
Related Articles
Helicobacter pylori infection and hyperemesis gravidarum: a systematic review and meta-analysis of case-control studies
Acta Obstetricia et Gynecologica Scandinavica, 12/02/09
Relevance Score: 69%%
Clarithromycin–Amoxycillin-Containing Triple Therapy: A Valid Empirical First-Line Treatment for Helicobacter pylori Eradication in Hong Kong
Helicobacter, 11/09/09
Relevance Score: 69%%
Upper gastrointestinal bleeding in children with haemophilia: a clinical significance of Helicobacter pylori infection
Haemophilia, 11/09/09
Relevance Score: 69%%
Helicobacter pylori Multiplex Serology
Helicobacter, 11/09/09
Relevance Score: 68%%
Host Single Nucleotide Polymorphisms of MMP-9 -1562/TIMP-1 372 Have Gender Differences in the Risk of Gastric Intestinal Metaplasia After Helicobacter pylori Infection
Helicobacter, 11/09/09
Relevance Score: 68%%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Correlation between Vancomycin MIC Values and Those of Other Agents against Gram-Positive Bacteria among Patients with Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy, 12/02/09
Potential for False Resistance to Pyrazinamide when Using the BACTEC MGIT 960 System for Susceptibility Testing of M. tuberculosis
Journal of Clinical Microbiology, 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of free radicals in liver diseases
Hepatology International, 12/02/09
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09

See Latest Articles